Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Roche
|
| gptkbp:acquisitionYear |
2018
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
NLRP3 inflammasome inhibitors
development of therapies for liver diseases |
| gptkbp:foundedIn |
gptkb:San_Diego,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Jecure Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:status |
subsidiary of Roche
|
| gptkbp:website |
https://www.jecuretx.com/
|
| gptkbp:bfsParent |
gptkb:Versant_Ventures
|
| gptkbp:bfsLayer |
7
|